Skip to main content

MARSHALL WACE, LLP

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in HALO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$14,742,467
+$6,921,851 QoQ
Shares Held
188,354
+55.7% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#96
of 667 holders
Holding Since
Jun 2022
13 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. HALO ranks #52 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HALO

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,742,467 188,354
2026-03-31 $7,820,616 121,006
2025-12-31 $33,461,559 497,200
2025-09-30 $28,877,991 393,755
2025-06-30 $20,242,594 389,131
2025-03-31 $29,582,826 463,608
2024-12-31 $211,607 4,426
2024-03-31 $3,072,682 75,533
2023-12-31 $23,882,369 646,168
2023-09-30 $104,087,779 2,724,811
2023-06-30 $83,809,473 2,323,523
2023-03-31 $33,976,382 889,667
2022-06-30 $4,877,884 110,861